Related Experiment Video
Updated: Mar 16, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
[INSULIN RESISTANCE ASSOCIATED WITH METABOLIC SYNDROME AS AN INDICATOR OF CARDIOVASCULAR RISK]
Insights
Metabolic syndrome significantly elevates blood insulin levels and insulin resistance in coronary heart disease (CHD) patients. This indicates increased cardiovascular risk due to associated factors like dyslipidemia and inflammation.
Area of Science:
- Cardiology
- Metabolic Disorders
- Biochemistry
Background:
- Coronary heart disease (CHD) poses a significant global health burden.
- Metabolic syndrome (MS) is increasingly recognized as a major risk factor for cardiovascular diseases.
- Understanding the interplay between MS, insulin levels, and cardiovascular risk factors in CHD patients is crucial.
Purpose of the Study:
- To investigate blood insulin levels in patients with CHD, comparing those with and without MS.
- To examine the relationship between insulin levels, insulin resistance, and various cardiovascular risk factors in CHD patients.
Main Methods:
- A cohort of 127 stable CHD patients (63 with MS, 64 without MS) and 80 healthy controls were studied.
- Blood insulin, glycated hemoglobin (HbA1c), lipids (total cholesterol, HDL, triglycerides), and inflammatory markers (oxidized LDL, IL-1β, IL-6, TNF-α) were measured.
- Insulin resistance was assessed using the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) index, and depression was evaluated using the Zung scale.
Main Results:
- CHD patients with MS exhibited significantly higher blood insulin levels (15.5 mcIE/ml) compared to those without MS (9.5 mcIE/ml) and healthy controls (6.3 mcIE/ml) (p < 0.001).
- HOMA-IR showed a direct correlation with waist circumference, HbA1c, total cholesterol, triglycerides, oxidized LDL, IL-1β, IL-6, and TNF-α.
- HOMA-IR demonstrated a negative correlation with HDL cholesterol levels.
Conclusions:
- Metabolic syndrome in CHD patients is associated with hyperinsulinemia, insulin resistance, elevated HbA1c, dyslipidemia, and increased pro-inflammatory cytokines.
- The strong correlation between HOMA-IR and key pathogenetic factors suggests its utility as a cardiovascular risk indicator in CHD patients with MS.
- These findings highlight the complex metabolic dysregulation in CHD patients with MS and underscore the need for comprehensive risk management.
Aim:
To study blood insulin level in patients with coronary heart disease (CHD) with and without metabolic syndrome (MS) and its relation to cardiovascular risk factors.
Materials And Methods:
We examined 127 patients with stable coronary heart disease (mean age 59.4 ± 5.7 yr) including 63 with MS and 64 without it. The control group consisted of 80 practically healthy subjects. Bloods insulin was determined by immunochemoluminescence, glycated hemoglobin (HbA,) by immunoturbidimetry, total cholesterol, HDLP cholesterol and triglycerides by enzymatic colorimetric method, oxidized LDLP IL-l, IL-6, and tunour necrosis factor-α by enzyme immunoassay. The degree of depression was estimated using the Zung scale.
Results:
Blood insulin level in healthy subjects, CHD patients with and without MS was 6.3 (6.20;6.62), 15.5 (13.96, 16.3) and 9.5 (9.2, 10.1) mcIE/ml respectively (p < 0.001). HOMA-IR directly correlated with MBI, waist circumference, HbA1-total cholesterol, triglyceride, oxidized LDLP IL-1β, IL-6, and tumour necrosis factor-α levels and negatively with the HDLP cholesterol level.
Conclusion:
In patients with CHD, metabolic syndrome is associated with a set of additional cardiovascular risk factors, viz. hyperinsulinemia, insulin resistance, increased HbA1c level, dyslipidemia, oxidative modification of LDLP activation of proinflammatory cytokines, and depressive disorders. Close correlation of HOMA-IR with certain pathogenetic factors ofCHD allow to use it as an indicator of cardiovascular risk in patients with CHD and MS.
Related Concept Videos
Coronary Artery Disease I: Introduction
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Insulin: The Receptor and Signaling Pathways
Cholesterol: Significance and Regulation
Considering cholesterol and...
Diabetes: Symptoms, Diagnosis, and Complications

